sunday may 31, 2020 - sakk · advanced rectal cancer: final results of prodige 23 phase iii trial,...

09:00 Introduction 09:00 ‐ 12:00 Gastro‐Intestinal Presentedby: Dr. med. DanielHelbling, Prof. Dr. med. Ulrich Güller Live experts: Dr. med. Sara De Dosso, Dr. Stefanie Hayoz, Prof. Dr. med. Wolfram Jochum, PD Dr. med. Ulf Petrausch, Prof. Dr. med. Daniel R. Zwahlen, PD Dr. med. univ. Thomas Winder Abstract no Entity First Author Titel Link to the video 4505 Upper GI Ghaneh ESPAC‐5F: Four‐arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer. https://meetinglibrary.asco.org/record/185467/video 4502 Upper GI Hofheinz Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2‐positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA multicenter randomized phase II trial of the AIO. https://meetinglibrary.asco.org/record/186001/video 4004 Lower GI Sobrero Overall survival (OS) and long‐term disease‐free survival (DFS) of three versus six months of adjuvant (adj) oxaliplatin and fluoropyrimidine‐based therapy for patients (pts) with stage III colon cancer (CC): Final results from the IDEA (International Duration Evaluation of Adj chemotherapy) collaboration https://meetinglibrary.asco.org/record/185483/video 4002 Lower GI Lonardi First‐line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS‐BRAF wild‐type metastatic colorectal cancer elderly patients: The PANDA study. https://meetinglibrary.asco.org/record/185499/video 4001 Lower GI Koepetz Encorafenib plus cetuximab with or without binimetinib for BRAF V600E metastatic colorectal cancer: Updated survival results from a randomized, three‐arm, phase III study versus choice of either irinotecan or FOLFIRI plus cetuximab (BEACON CRC). https://meetinglibrary.asco.org/record/185472/video Break 4007 Lower GI Conroy Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: Final results of PRODIGE 23 phase III trial, a UNICANCER GI trial. https://meetinglibrary.asco.org/record/185485/video 4006 Lower GI Hospers Short‐course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer: The randomized RAPIDO trial. https://meetinglibrary.asco.org/record/185464/abstract 4008 Lower GI Garcia‐Aguilar Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial. https://meetinglibrary.asco.org/record/187194/video Discussion of 4006‐8 Lower GI Leigh Hallemeier Time to Reflect on What We Do Below the Peritoneal Reflection https://meetinglibrary.asco.org/record/187289/video Wrap‐Up All: Panda, Beacon, Prodige23 and Rapido Sunday / May 31, 2020

Upload: others

Post on 27-Jul-2020

2 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: Sunday May 31, 2020 - SAKK · advanced rectal cancer: Final results of PRODIGE 23 phase III trial, a UNICANCER GI trial. 4006 Lower GI Hospers Short‐course radiotherapy followed

09:00 Introduction

09:00 ‐ 12:00 Gastro‐Intestinal

Presented by: Dr. med. Daniel Helbling, Prof. Dr. med. Ulrich GüllerLive experts: Dr. med. Sara De Dosso, Dr. Stefanie Hayoz, Prof. Dr. med. Wolfram Jochum, PD Dr. med. Ulf Petrausch, Prof. Dr. med. Daniel R. Zwahlen, PD Dr. med. univ. Thomas Winder

Abstract no Entity First Author Titel Link to the video

4505 Upper GI Ghaneh

ESPAC‐5F: Four‐arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer. https://meetinglibrary.asco.org/record/185467/video

4502 Upper GI Hofheinz

Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2‐positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA multicenter randomized phase II trial of the AIO. https://meetinglibrary.asco.org/record/186001/video

4004 Lower GI Sobrero

Overall survival (OS) and long‐term disease‐free survival (DFS) of three versus six months of adjuvant (adj) oxaliplatin and fluoropyrimidine‐based therapy for patients (pts) with stage III colon cancer (CC): Final results from the IDEA (International Duration Evaluation of Adj chemotherapy) collaboration https://meetinglibrary.asco.org/record/185483/video

4002 Lower GI LonardiFirst‐line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS‐BRAF wild‐type metastatic colorectal cancer elderly patients: The PANDA study. https://meetinglibrary.asco.org/record/185499/video

4001 Lower GI Koepetz

Encorafenib plus cetuximab with or without binimetinib for BRAF V600E metastatic colorectal cancer: Updated survival results from a randomized, three‐arm, phase III study versus choice of either irinotecan or FOLFIRI plus cetuximab (BEACON CRC). https://meetinglibrary.asco.org/record/185472/video

Break

4007 Lower GI ConroyTotal neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: Final results of PRODIGE 23 phase III trial, a UNICANCER GI trial. https://meetinglibrary.asco.org/record/185485/video

4006 Lower GI HospersShort‐course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer: The randomized RAPIDO trial. https://meetinglibrary.asco.org/record/185464/abstract

4008 Lower GI Garcia‐Aguilar Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial. https://meetinglibrary.asco.org/record/187194/videoDiscussion of 4006‐8 Lower GI Leigh Hallemeier Time to Reflect on What We Do Below the Peritoneal Reflection https://meetinglibrary.asco.org/record/187289/videoWrap‐Up All: Panda, Beacon, Prodige23 and Rapido

Sunday / May 31, 2020

Võrtsjärve rattarada - files.voog.comfiles.voog.com/0000/0012/9655/files/Võrtsjärve rattarada.pdf · ja ja ja ja gi gi gi gi ja gi gi ja gi ja ja gi ja ja gi gi ja ja gi V ä

web.oncoletter.chweb.oncoletter.ch/files/cto_layout/Kongressdateien/ASCO-GI 2017/C05... · Rapido trial, results awaited Locally advanced Rectal Cancer International randomized multicentre

BASQUE COAST GEOPARK Saturraran BAY OF · PDF filebasque coast geopark gÉoparc de la cÔte basque gi-3292 n-634 gi-631 gi-631 gi-3230 gi-638 gi-638 gi-3291 gi-3210 a-8 gi-3706 gi-2633

WEDSTRIJDREGLEMENT BJJ (Gi & No Gi)

MS GI &DigestiveMS GI &DigestiveMS GI &DigestiveMS GI &DigestiveMS GI &DigestiveMS GI &DigestiveMS GI &DigestiveMS GI &DigestiveMS GI &DigestiveMS GI &DigestiveMS GI &DigestiveMS GI

guia ge gi gue gi

PALNIKÓW GAZOWO-OLEJOWYCH GI/EMME 1400 GI ......2 SPIS TREŒCI GI/EMME 1400-2000-3000-4500 Model GI/EMME1400 GI/EMME2000 GI/EMME3000 GI/EMME4500 Modulacja minimalna kcal/h 350.000

Introducción Al Análisis Filosófico 1 (John Hospers)

Hospers on Libertarianism

HOSPERS TELEPHONE EXCHANGE, INC. d/b/a HTC … · hospers telephone exchange, inc. d/b/a htc communications services catalog local services access services concurrence december 1,

Voortgang 2015 Monique Hospers-Brands Thomas Pollema … · 2016. 2. 11. · Ir. Monique Hospers -Brands, Thomas Pollema, Michiel Bus . Zoekwoorden: bodemvruchtbaarheid, maaimeststoffen,